IPA is fully prepared to respond to the demand and use of alternative transgenic species in novel antibody generation.
The Wnt-Surrogate-Fc Fusion Protein is an important growth factor in the field of organoid technology
Attendees will obtain corporate updates from the premier Canadian publicly traded and private companies through presentations and private meetings.
Dr. Nixon brings unique experience and expertise that is directly relevant to IPA.
The alliance is focused on the discovery of antibodies against three undisclosed therapeutically-relevant ion-channels.